[PDF] Top 20 Trabajo Colaborativo Fase 2 GRUPO 203058 18
Has 10000 "Trabajo Colaborativo Fase 2 GRUPO 203058 18" found on our website. Below are the top 20 most common "Trabajo Colaborativo Fase 2 GRUPO 203058 18".
Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
... to fibrosing ILDs with a progressive phenotype), the next decisive question is how the term “progressive” should be ...state-of-the-art management, including in many cases the use of ... See full document
235
Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence
... how treatment should be initiated, but the decision to treat is centred around three factors: risk of severe dysfunction or irreversible damage to major organs, risk of death or the presence of incapacitating, ... See full document
7
The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
... a progressive-fibrosing phenotype, their incidence and prevalence are not well ...a progressive-fibrosing phenotype appear to be more common in older adults and are associated with a complex ... See full document
92
Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases
... of fibrosing HP with a UIP pattern is similar to IPF, whereby progression occurs despite treatment with an agent considered appropriate for the ...appears progressive may stabilise in the longer term ... See full document
12
Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases
... a progressive fibrosing phenotype is proposed to be an acute, clinically significant, respiratory deterioration radiologically characterised by a new widespread alveolar abnormality typically occurring ... See full document
23
Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases
... This treatment relies on access to oxygen, and requires patients to carry, push or pull tanks and to wear a cannula or have a catheter to breathe in the ... See full document
176
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
... of fibrosing non-IPF ILDs that experienced a progressive decline in lung function during treatment with corticosteroids and/or immuno- modulators between October-2014 and ...quantify ... See full document
210
Fibrosing interstitial lung diseases: knowns and unknowns
... of fibrosing interstitial lung disease (ILD) are at risk of developing a progressive phenotype characterised by self-sustaining fibrosis, decline in lung function, worsening quality of ... See full document
11
Acute exacerbations of progressive-fibrosing interstitial lung diseases
... optimal management of AE in ILDs. In IPF, international management guidelines recommend the use of supportive care with symptom palliation and long-term oxygen therapy (for patients with resting hypoxaemia) ... See full document
63
Role of imaging in progressive-fibrosing interstitial lung diseases
... and lung biopsy, guide treatment strategies and predict treatment outcomes ...Surgical lung biopsy is unfeasible in many patients and, consequently, efforts are being made to minimise the need ... See full document
21
Computer-aided detection in chest radiography based on artificial intelligence: a survey
... traditional lung segmentation method requires human intervention and a priori knowledge of the dependence of the problems, the deep learning extractor has effectively replaced manual feature ...the lung ... See full document
7
Pulmonary hypertension in chronic interstitial lung diseases
... of interstitial lung diseases (ILDs), particularly in idiopathic pulmonary fibrosis and ILD associated with connective tissue ...other lung diseases, such as combined pulmonary fibrosis ... See full document
9
Quantitative Analysis of Thoracic Computed Tomography Images
... the lung lose elastic recoil and therefore do not change appreciably in volume between inspiration and ...by lung parenchymal areas that are not emphysematous but which fail to increase in attenuation (or ... See full document
11
Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1
... organizing pneumonia, sarcoidosis, HP and non-specific interstitial pneumonia [17-19]. However, this is the first time that TNC synthesis has been evaluated together with other glycoproteins in IPF lungs, and it ... See full document
96
Cefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis: serum inflammatory biomarkers, clinical efficacy, and microbiological eradication
... of treatment), and evaluations were performed during treatment (visit 2, days 2–4), at the end of treatment (visit 3, test-of-cure visit, days 6–9), and at follow-up (visit 4, late post therapy ... See full document
8
Cellular interactions in the pathogenesis of interstitial lung diseases
... Polymorphonuclear cells have long been recognised to infiltrate the lungs of patients affected by IPF [126], yet still the contribution of these cells in the pathogenesis of the disease is a matter of debate [127]. Their ... See full document
16
Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study
... The poor survival of patients with AE-IPF is a great challenge. The MST of these patients was about 3–4 months [6, 7]. Nearly half of patients with AE-IPF died in the hospital, and patients with both definite AE-IPF and ... See full document
30
Multidisciplinary evaluation of interstitial lung diseases: current insights
... A related issue is whether all cases of suspected ILD require MDT characterisation. This might be dictated by the experience of the MDT group. New groups formed by less experienced participants, dealing with smaller ... See full document
67
Diffuse smoking-related lung diseases: insights from a radiologic-pathologic correlation
... upper lung predomin- ance of the findings, characterized by the evidence of low attenuation centriacinar nodules, GGOs, bronchial wall thickening, few thickened interlobular septa, and also lobular air-trapping, ... See full document
17
Endotoxin markers in bronchoalveolar lavage fluid of patients with interstitial lung diseases
... neutrophils, but not in monocytes/macrophages or lym- phocytes, was observed in BALf three hours after inhal- ation [29]. The negative relation of LPS to macrophages (R = −0.25, p < 0.05) in our study may reflect an ... See full document
19
Related subjects